Obsessive-Compulsive Disorder Clinical Trial
Official title:
Internet-delivered Attention Training for Obsessive-Compulsive Disorder
Verified date | November 2014 |
Source | Humboldt-Universität zu Berlin |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Interventional |
The goal of this study is to investigate an attention training program for participants with
Obsessive-Compulsive Disorder. The attention training consists of a modified dot probe task
with picture stimuli related to washing and checking paired with neutral pictures.
Participants are randomly assigned to an experimental and a placebo-control group. After a
minimum of 4 weeks of attention training we expect to find differences between participants
of the experimental and the control group in terms of attention bias, OCD symptoms, anxiety
and depression.
Status | Completed |
Enrollment | 108 |
Est. completion date | July 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - diagnosis of primary OCD according to OCI-R self report (cut-off >=18) Exclusion Criteria: - suicidal - substance abuse or addiction - psychotic symptoms - visual impairment if not compensated with optical aid Current treatment is not an exclusion criterion, but data on treatment status (current psycho- or pharmacotherapy for OCD) will enter our statistical analyses. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Germany | Humboldt-Universität zu Berlin | Berlin |
Lead Sponsor | Collaborator |
---|---|
Humboldt-Universität zu Berlin |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Beck Anxiety Inventory (BAI) T1 | The BAI measures severity of anxiety symptoms. | pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires) | No |
Other | Beck Anxiety Inventory (BAI) T2 | The BAI measures severity of anxiety symptoms. | post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set) | No |
Other | Beck Anxiety Inventory (BAI) T3 | The BAI measures severity of anxiety symptoms. | follow-up, between day 27 and 50 after T2 questionnaires (time limit set) | No |
Other | Beck Depression Inventory II (BDI-II) T1 | The BDI measures severity of depressive symptoms. | pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set, all further steps relative to exact time point of T1 questionnaires) | No |
Other | Beck Depression Inventory II (BDI-II) T2 | The BDI measures severity of depressive symptoms. | post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set) | No |
Other | Beck Depression Inventory II (BDI-II) T3 | The BDI measures severity of depressive symptoms. | follow-up, between day 27 and 50 after T2 questionnaires (time limit set) | No |
Other | Attention bias towards OCD-relevant stimuli at T1 measured with a dot-probe task. | Attention bias is measured using a dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented briefly on a computer screen. Next, a probe randomly appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard. Attention bias is calculated as the mean difference in reaction times between trials in which the probe appears at the OCD-relevant location vs. trials in which it appears at the neutral location. The bias assessment session is masked as first training sessions in both groups. |
after T1 questionnaires and pre-treatment, estimated: between day 1 and 3 after T1 questionnaires (no time limit set) | No |
Other | Attention bias towards OCD-relevant stimuli at T2 measured with a dot-probe task. | Attention bias is measured using a dot-probe task. In this task pairs of pictures (OCD-relevant/neutral) are presented briefly on a computer screen. Next, a probe randomly appears on one of the two former picture locations. Participants have to react to that probe by pressing the corresponding button on the keyboard. Attention bias is calculated as the mean difference in reaction times between trials in which the probe appears at the OCD-relevant location vs. trials in which it appears at the neutral location. |
post-treatment, after a minimum of 8 training sessions over a time of 4 weeks, estimated: between day 1 and 4 after last training session (no time limit set) | No |
Primary | Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T1 | The Y-BOCS-SRS measures severity of OCD symptoms. | pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set) | No |
Primary | Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T2 | The Y-BOCS-SRS measures severity of OCD symptoms. | post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set) | No |
Primary | Yale-Brown Obsessive-Compulsive Scale Self-Report Scale (Y-BOCS-SRS) T3 | The Y-BOCS-SRS measures severity of OCD symptoms. | follow-up, between day 27 and 50 after T2 questionnaires (time limit set) | No |
Secondary | Obsessive-Compulsive Inventory-Revised (OCI-R) T1 | The OCI-R measures severity of OCD symptoms. | pre-treatment, estimated: between day 1 and day 7 after enrolment (no time limit set) | No |
Secondary | Obsessive-Compulsive Inventory-Revised (OCI-R) T2 | The OCI-R measures severity of OCD symptoms. | post-treatment, between day 1 and 6 after T2 Bias Assessment (time limit set) | No |
Secondary | Obsessive-Compulsive Inventory-Revised (OCI-R) T3 | The OCI-R measures severity of OCD symptoms. | follow-up, between day 27 and 50 after T2 questionnaires (time limit set) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |